High-yield points
- Evaluate endocrine function guided by the clinical picture. Endocrine dysfunction occurs even with lesions under 10 mm .
- Incidental pituitary lesions rarely cause problems. Monitor them clinically .
- Prolactinoma: cabergoline first .
- Cushing disease: transsphenoidal surgery, with about 91% immediate and 82% sustained remission .
- Gigantism: endoscopic surgery was associated with higher cure rates, but the endoscopic numbers are tiny (6 of 9) .
- Rathke cleft cyst:
- Operate for vision, not for headache.
- Endocrine outcome often worsens after surgery (44%).
- Fenestration: more recurrence but less endocrinopathy .
- Suprasellar arachnoid cyst: endoscopic VCC was associated with fewer reoperations than ventriculocystostomy (RR 0.33, observational studies). Infants re-operate more .
- Isolated stalk thickening:
- about 1 in 3 prove to be germinoma, LCH or lymphoma (diabetes insipidus was common but not predictive);
- progressive thickening, especially of the whole stalk, is the red flag;
- check AFP and β-hCG, then serial MRI .
Sellar lesions in children range from incidental cysts that need no treatment to functioning adenomas that need curative surgery. Craniopharyngioma has its own topic. This topic covers:
- pituitary adenomas (pituitary neuroendocrine tumors);
- Rathke cleft cysts;
- suprasellar arachnoid cysts;
- pituitary stalk thickening, including germinoma and Langerhans cell histiocytosis (LCH);
- incidental findings.
Endocrine evaluation should be guided by the clinical picture, but don't skip it just because a lesion is small .
The general approach
- Population-based cohort of 104 children with sellar or parasellar lesions :
- Endocrine dysfunction at presentation varied by lesion type and was most frequent with pituitary adenomas.
- By size at presentation: 74.2% with lesions ≥10 mm vs. 49.2% with lesions <10 mm.
- After treatment: endocrine abnormalities in 64.5% vs. 13.1% by the same size cut-off.
- Even small lesions caused clinically relevant abnormalities. The authors advise endocrine evaluation based on clinical context, with longitudinal surveillance.
- Baseline workup (see caveats):
- Pituitary MRI with thin sellar cuts.
- Hormones: morning cortisol, free T4/TSH, prolactin, IGF-1, gonadotropins and sex steroids, plus sodium and osmolality for diabetes insipidus.
- Formal visual fields.
- Suprasellar or stalk lesions: add serum and CSF AFP and β-hCG .
Pituitary incidentalomas
- Incidental pituitary lesions (35 children, median follow-up 23 months) :
- Size: mostly microincidentalomas (<10 mm), and most were cystic. 4 of 25 micro lesions grew to ≥10 mm.
- Outcome: no child developed an endocrinopathy or new neurologic symptoms.
- Implication: in the absence of new symptoms, clinical monitoring may be enough, rather than repeated imaging.
Pituitary adenomas (pituitary neuroendocrine tumors)
- Prolactinoma (160 children and adolescents with hyperprolactinemia) :
- Causes were mostly non-pituitary:
- polycystic ovary syndrome;
- drugs;
- macroprolactin;
- idiopathic.
- Pituitary or hypothalamic causes (38): prolactinoma in 18, non-functioning adenoma in 8, craniopharyngioma in 7 and empty sella in 5.
- Treatment: cabergoline succeeded in all prolactinomas.
- Implication: a prolactinoma is medical, not surgical, first-line disease.
- Cushing disease (22 children, transsphenoidal surgery) :
- Localization: MRI found the adenoma in 81.8%, mostly microadenomas. Bilateral inferior petrosal sinus sampling lateralized in 73.7%.
- Remission: immediate in 90.9%, recurrence 10%, and sustained remission 81.8%.
- Implication: transsphenoidal surgery is first-line, ideally in a specialized center.
- Gigantism (growth hormone–secreting adenomas) :
- Pooled pediatric surgical cure: historically 24.7%.
- By approach: endoscopic endonasal 66.7% (6/9) vs. microscopic 20.5%.
- Hypopituitarism or diabetes insipidus: 31.1% after microscopic vs. 6.8% after endoscopic surgery.
- Caveat: the endoscopic numbers are small.
- Non-functioning macroadenomas are less common in children than in adults. Surgery is for visual or mass effect (see caveats).
Rathke cleft cysts
- Pediatric series of 93 patients (41 operated, 52 observed; mean follow-up 5.6 years; cysts ≥10 mm) :
- Headache: improved in 86.2% after surgery, vs. 70.0% with observation, which was not different.
- Visual problems improved in 93.3% after surgery. They are the main surgical indication.
- Endocrine function after surgery:
- deteriorated in 43.9%;
- improved in only 14.6%.
- Recurrence: 17.1%, with reoperation in 4.9%.
- Fenestration with partial wall resection vs. total wall resection:
- more recurrence (26.9%);
- less endocrine injury.
- Natural history (410 patients, mostly adults; 279 observed, median 124 months) :
- Course: 16.1% progressed, 63.1% stayed stable and 20.8% regressed.
- Predictors of progression: >10 mm (24.8%) and entirely suprasellar location (30.1%). Small cysts without suprasellar extension progressed only 8.5% of the time.
- Surgery during follow-up: 7.5%.
- Children's endocrine course (35 children with Rathke cleft cyst) :
- On follow-up: 25% (5 of 20) developed endocrine disorders.
- At diagnosis: older age and larger cysts were associated with endocrine problems.
- Practical rule:
- Observe small, asymptomatic cysts with endocrine and MRI follow-up.
- Operate for visual compromise or clear progression, through an endoscopic endonasal approach.
Suprasellar arachnoid cysts
- Who they affect: they elevate the chiasm and the third ventricle floor.
- Typical presentations: hydrocephalus, macrocephaly, visual loss, endocrine disturbance (including precocious puberty) or the "bobble-head doll" sign (see caveats).
- Endoscopic treatment (meta-analysis, 19 studies: 94 VCC and 427 ventriculocystostomy patients) :
- Ventriculocystocisternostomy (VCC), which opens both the upper and the lower cyst walls, cut reoperation compared with ventriculocystostomy alone (risk ratio 0.33).
- Complications: 16.7% vs. 12.7%, not significantly different.
- Infants under 1 year had more reoperations: 29.4% vs. 5.7%.
Pituitary stalk thickening
- Isolated stalk thickening (40 children, median follow-up 5.2 years) :
- Pituitary dysfunction: in 85%, mostly central diabetes insipidus.
- Proliferative disease: 35% were eventually diagnosed, at a median of 1.3 years:
- germinoma, 8;
- LCH, 5;
- lymphoma, 1.
- Predictors:
- progressive thickening over time (86% vs. 4% in presumed hypophysitis);
- thickening of the entire stalk (56% vs. 27%);
- a heterogeneous "sack of marbles" enhancement pattern, which suggested germinoma.
- Second series (18 children) :
- Initial workup (blood counts, serum and CSF tumor markers, skeletal survey) diagnosed no neoplasm.
- Progression: 27.7% progressed and went to biopsy (germinoma 2, LCH 2, inconclusive 1).
- The others: stable or resolved.
- Implication: in this small series, serial MRI can be safe, and not every case needs an upfront biopsy.
- A mimic: the normal pubertal gland can be physiologically enlarged with an upward-convex surface. Don't mistake it for a tumor (see caveats).
Related topics
- Craniopharyngioma in Children: the commonest childhood sellar-suprasellar tumor.
- Arachnoid Cysts in Children: suprasellar cyst management.
- Tumors of the Pineal Region: germinoma diagnosis and treatment.
- Optic Pathway Gliomas: chiasmatic-hypothalamic mass in the differential.
- Hypothalamic Hamartoma: another hypothalamic lesion.
References
- El Mouallem R, Leopold K, Saba L, et al. Pediatric sellar and parasellar lesions: a population-based cohort study of presentation, management, and endocrine outcomes. Pituitary 2026;29(6). doi:10.1007/s11102-026-01765-8. PMID 42888329. verified
- Miller HK, Rajan VP, Blunden C, et al. Thickened but unclear: clinical course of isolated pituitary stalk thickening in the pediatric age group. Neurooncol Pract 2026;13(2):408–414. doi:10.1093/nop/npaf118. PMID 42111021. verified
- Waselewski AC, Walsh LM, Holste KG, et al. Natural history of pituitary incidentalomas in pediatric patients: a single-center, retrospective analysis. J Clin Endocrinol Metab 2026;111(7):e1848–e1854. doi:10.1210/clinem/dgag047. PMID 41637571. verified
- Kilci F, Sarikaya E, Murat NÖ, et al. Hyperprolactinemia in children and adolescents: clinical characteristics and etiological spectrum. Eur J Pediatr 2025;184(6):366. doi:10.1007/s00431-025-06200-x. PMID 40437161. verified
- Wang B, Zhang H, Su T, et al. The neurosurgical outcome of pediatric Cushing's disease in a single center from China: a 20-year experience. Front Endocrinol (Lausanne) 2025;16:1663624. doi:10.3389/fendo.2025.1663624. PMID 40969365. verified
- Garton ALA, Guadix SW, Vuguin PM, et al. Higher surgical cure of pediatric gigantism with endoscopic endonasal surgery: case series and review of the literature. Pituitary 2026;29(4). doi:10.1007/s11102-026-01738-x. PMID 42538445. verified
- Lee JS, Kim YH, Koh EJ, et al. Surgical indication of pediatric Rathke's cleft cyst based on a 20-year retrospective cohort. J Neurosurg Pediatr 2023;32(6):729–738. doi:10.3171/2023.7.PEDS23181. PMID 37657098. verified
- Amano K, Oda Y, Kawamata T. Natural history and radiological features of Rathke's cleft cysts diagnosed on MRI: analysis of 410 patients including 279 managed conservatively. Clin Neurol Neurosurg 2026;267:109456. doi:10.1016/j.clineuro.2026.109456. PMID 42070424. verified
- Tuli G, Munarin J. Craniopharyngioma, Rathke cleft cyst, and empty sella natural history and endocrine outcome in pediatric age: a single tertiary center experience over the 2000–2024 period. Neuroendocrinology 2025;115(12):929–934. doi:10.1159/000546493. PMID 40388897. verified
- Guldberg F, Stauning AT, Larsen CC, et al. Endoscopic treatment methods of suprasellar arachnoid cysts in children: a systematic review and meta-analysis. Neurosurg Rev 2025;49(1):26. doi:10.1007/s10143-025-03935-x. PMID 41286181. verified
- Bennett J, Nobre L, Bouffet E, et al. Stalking the stalk: isolated pituitary stalk thickening and predictive factors for proliferative disease. Neurooncol Adv 2024;6(1):vdae214. doi:10.1093/noajnl/vdae214. PMID 39734811. verified
Verification (2026-11-17):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Numbers were checked against the PubMed abstracts.
- References 1 and 6 are 2026 articles without page or article numbers in PubMed.
Caveats:
- The following are standard teaching, not drawn from the cited abstracts:
- the baseline hormone panel;
- non-functioning macroadenoma indications;
- suprasellar arachnoid cyst presentations (including the bobble-head doll sign);
- the physiologic pubertal gland mimic.
- Reference 8's abstract does not give ages; it is presumed to be mainly adults.
- The following are standard teaching: the Rathke cleft cyst "practical rule" and the VCC description.
- Reference 9's endocrine follow-up figure (5 of 20) refers to the Rathke cleft cyst patients with follow-up data.
- The figure is an original schematic.